Raymond James & Associates’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,217
Closed -$332K 3796
2019
Q3
$332K Buy
+10,217
New +$294K ﹤0.01% 2950
2018
Q3
Sell
-4,389
Closed -$209K 3771
2018
Q2
$209K Buy
+4,389
New +$200K ﹤0.01% 3240
2017
Q4
Sell
-4,125
Closed -$203K 3579
2017
Q3
$203K Buy
+4,125
New +$186K ﹤0.01% 3039
2015
Q4
Sell
-120,530
Closed -$4.78M 2424
2015
Q3
$4.78M Sell
120,530
-1,460
-1% -$70.6K 0.02% 773
2015
Q2
$6.42M Buy
121,990
+21,088
+21% +$1.14M 0.02% 699
2015
Q1
$5.69M Buy
100,902
+5,860
+6% +$342K 0.03% 679
2014
Q4
$5.55M Buy
95,042
+4,658
+5% +$261K 0.03% 631
2014
Q3
$4.98M Buy
90,384
+5,556
+7% +$322K 0.03% 636
2014
Q2
$4.88M Buy
84,828
+5,729
+7% +$312K 0.03% 643
2014
Q1
$4.49M Buy
79,099
+5,155
+7% +$265K 0.03% 623
2013
Q4
$3.59M Buy
73,944
+5,570
+8% +$278K 0.03% 665
2013
Q3
$3.61M Buy
68,374
+4,603
+7% +$232K 0.03% 604
2013
Q2
$3.01M Buy
+63,771
New +$3.29M 0.03% 625

Other funds holding IPHS

Raymond James & Associates's IPHS Position: Q4 2019 in Review

Raymond James & Associates sold out of Innophos Holdings, Inc. (IPHS) in Q4 2019, closing a stake of 10,217 shares — an estimated $332K sold.

Raymond James & Associates first reported a position in IPHS in Q2 2013 and held it in 13 quarters. The position peaked at $6.42M in Q2 2015. 154 funds tracked by Wall St. Rank hold IPHS as of Q4 2019.

  • Raymond James & Associates reported no remaining Innophos Holdings, Inc. position as of Q4 2019 after selling out during the quarter.
  • Raymond James & Associates sold 10,217 Innophos Holdings, Inc. shares in Q4 2019, an estimated $332K.
  • Raymond James & Associates first reported a position in Innophos Holdings, Inc. in Q2 2013 and held it in 13 quarters.
  • Raymond James & Associates's Innophos Holdings, Inc. position peaked at $6.42M in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q4 2019.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.